UNC Health brings COVID-19 treatments directly from the lab to the patient bedside.

UNC Health is uniquely poised in the fight against the COVID-19 pandemic. With a team of career leaders in pulmonary diseases and coronaviruses combined with an unparalleled culture of collaboration across campus departments, UNC Health has emerged as a world leader in COVID-19 research.

At the forefront of this groundbreaking work is William Fischer, MD, Associate Professor of Medicine in UNC School of Medicine’s Division of Pulmonary Diseases and Critical Care Medicine. Dr. Fischer is a specialist in severe viral infections and acute respiratory distress syndrome.

Hear from Dr. Fischer as he explains how UNC Health enables round-the-clock COVID-19 research and intensive clinical care to happen simultaneously, moving potentially groundbreaking treatments directly from the laboratory to the patient bedside.

Dr. Fischer and countless other clinicians and scientists are working tirelessly to fight COVID-19 while also remaining dedicated to the highest quality research and clinical care across all areas of UNC Health.

Please make a gift today to ensure our work to change lives in North Carolina and beyond can continue.

Dr. Fischer works closely with Richard C. Boucher, MD, the James C. Moeser Eminent Distinguished Professor of Medicine and Director of Marsico Lung Institute and Ralph Baric, PhD, the William R. Kenan, Jr. Distinguished Professor in the Department of Epidemiology and Professor in the Department of Microbiology and Immunology. Together, UNC Health’s top researchers are building a platform to identify, test and advance the most promising therapeutic agents against COVID-19 through next-generation biological mapping and genetic sequencing.